Patent details
300691
Product Name:
Albiglutide
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
300691
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP1463751
Status:
Invalid because the basic patent has lapsed before the expiration date or has been revoked
Application number:
300691
Procedural language:
Dutch
First Applicant Residence Country:
Marketing Authorization
Marketing Authorization Number:
EU/1/13/908
Marketing Authorization Type:
EEA
Marketing Authorization Date:
26/03/2014
Marketing Authorization Country:
European Union (EU)
Dates
Filing date:
18/09/2014
First Marketing Authorization date:
26/03/2014
Grant date:
01/12/2016
Activation date:
23/12/2022
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
09/11/2015
SPC/SPC Extension Expiration Date:
22/12/2027
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:
Applicant/holder
From:
03/10/2014
Name:
GlaxoSmithKline Intellectual Property Limited
Address:
980 Great West Road, TW8 9GS, Brentford, Middlesex, United Kingdom (GB)
Historical Applicant/holder
From:
18/09/2014
To:
03/10/2014
Name:
Human Genome Sciences, Inc.
Address:
14200 Shady Grove Road, ROCKVILLE, MD 20850, United States of America (US)
Agent
Name:
ir. F.A. Geurts c.s.
From:
18/09/2014
Address:
Octrooibureau Vriesendorp & Gaade B.V.
Koninginnegracht 19, 2514 AB, Den Haag, Netherlands (NL)
To:
Publication
Bulletin
1
Bulletin Heading:
VRV
Journal edition number:
31/21
Publication date:
04/08/2021
Description:
Lapse or annulment
2
Bulletin Heading:
SPC
Journal edition number:
49/16
Publication date:
07/12/2016
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
3
Bulletin Heading:
SPC
Journal edition number:
46/15
Publication date:
11/11/2015
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
4
Bulletin Heading:
CO
Journal edition number:
2015/10
Publication date:
04/03/2015
Description:
Changes in the Netherlands Patent Register
5
Bulletin Heading:
SPC
Journal edition number:
2014/40
Publication date:
01/10/2014
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Deed
Change of owner(s)
Change Kind/ Decision Type:
Assignment
Deed Number:
023245-A023245-1
Date Registered:
03/10/2014
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. F.A. Geurts c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Other
Note:
Annual Fee
Annual Fee(s) Due Date:
31/12/2022
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date
Document type
Document Description
Number of pages
File Type
01/12/2016
Outgoing Correspondence
Decision grant
1
PDF
/1/9/6/0/0/0400300691/docs/300691_4_outgoingcorrespondence20161202022950926.pdf
01/12/2016
SPC Documents
Certificate SPC
1
PDF
/1/9/6/0/0/0400300691/docs/300691_8_supplprotectioncertificate20161202022951012.pdf
23/11/2016
Incoming Correspondence Paper
Accompanying letter incoming document
1
PDF
/1/9/6/0/0/0400300691/docs/300691_7_incomingcorrespondencepaper20210315043103228.pdf
13/10/2016
Outgoing Correspondence
Letter to applicant
2
PDF
/1/9/6/0/0/0400300691/docs/300691_9_outgoingcorrespondence20161014095032820.pdf
24/09/2014
Outgoing Correspondence
Outgoing Letter
1
PDF
/1/9/6/0/0/0400300691/docs/300691_1_outgoingcorrespondence20140924.pdf
18/09/2014
Application Form
First filed application form
3
PDF
/1/9/6/0/0/0400300691/docs/300691_0_applicationform20140918.pdf
18/09/2014
SPC Documents
Marketing Authorization SPC
3
PDF
/1/9/6/0/0/0400300691/docs/300691_2_supplprotectioncertificate20201021034803087.pdf
18/09/2014
SPC Documents
Summary of the characteristics of the product
43
PDF
/1/9/6/0/0/0400300691/docs/300691_3_supplprotectioncertificate20201021035358787.pdf
18/09/2014
SPC Documents
Accompanying letter SPC
2
PDF
/1/9/6/0/0/0400300691/docs/300691_5_supplprotectioncertificate20201021035118172.pdf
18/09/2014
SPC Documents
Annex SPC
1
PDF
/1/9/6/0/0/0400300691/docs/300691_6_supplprotectioncertificate20201021034939955.pdf